tiprankstipranks
BioNTech SE (BNTX)
NASDAQ:BNTX
US Market
BNTX
BioNTech SE
RESEARCH TOOLSreports
Want to see BNTX full AI Analyst Report?

BioNTech SE (BNTX) Income Statement

4,843 Followers

BioNTech SE Income Statement

Last quarter (Q4 2025), BioNTech SE's total revenue was €898.89M, a decrease of -24.46% from the same quarter last year. In Q4, BioNTech SE's net income was €-302.14M. See BioNTech SE’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 2.76B€ 2.75B€ 3.82B€ 17.31B€ 18.98B
Gross Profit
€ 2.14B€ 2.21B€ 3.22B€ 14.32B€ 16.07B
Operating Expenses
€ 2.76B€ 3.52B€ 2.53B€ 1.67B€ 781.40M
Depreciation and Amortization
€ 367.69M€ 298.00M€ 183.40M€ 123.30M€ 75.20M
EBITDA
€ -256.17M€ -367.10M€ 1.38B€ 13.10B€ 15.00B
Operating Income
€ -623.87M€ -1.31B€ 690.40M€ 12.64B€ 15.28B
Other Income/Expenses
€ -385.46M€ 636.60M€ 495.70M€ 311.40M€ -237.40M
Pretax Income
€ -1.01B€ -677.70M€ 1.19B€ 12.95B€ 15.05B
Net Income
€ -1.09B€ -665.30M€ 930.30M€ 9.43B€ 10.29B
Per Share Metrics
Basic EPS
€ -4.51€ -2.77€ 3.87€ 38.08€ 43.87
Diluted EPS
€ -4.51€ -2.77€ 3.83€ 37.09€ 41.21
Weighted Average Shares Outstanding
 241.70M 240.40M 240.60M 243.30M 244.00M
Weighted Average Shares Outstanding (Diluted)
 241.70M 240.40M 242.70M 249.80M 259.70M
Currency in EUR

BioNTech SE Earnings and Revenue History